MANILA, Philippines – Pharmaceutical company Pfizer applied for emergency use authorization (EUA) of its Pfizer-BioNTech COVID-19 vaccine for children aged 5 to 11 years old.
Philippine Food and Drug Administration (FDA) Director General Eric Domingo confirmed to Rappler on Sunday, December 12, that Pfizer submitted an application for the purpose the past week.
“[I]t is now under evaluation by our experts. We hope to make a decision before [the] end of the month. No other new applications,” added Domingo.
This comes after the US Food and Drug Administration on October 29 authorized the Pfizer-BioNTech vaccine’s use among 5- to 11-year-olds in the United States.
The FDA in June approved Pfizer’s request to allow its vaccine for use on adolescents aged 12 to 15.
In November, the Philippine government signed a deal with Pfizer for 20 million more vaccine doses, intended for booster shots and kids’ vaccinations. These doses will be delivered starting January 2022. – Rappler.com